Literature DB >> 22948067

Gender difference in the association of hyperuricemia with chronic kidney disease in southern China.

Zhibin Li1, Qinghua Liu, Haiping Mao, Zhijian Li, Xiuqing Dong, Yongwen Liu, Jianxiong Lin, Weiqing Chen, Hui Wang, Richard J Johnson, Xueqing Yu, Wei Chen.   

Abstract

BACKGROUND: The effect of hyperuricemia on chronic kidney disease (CKD) is controversial, and little is known about gender as it relates to hyperuricemia and CKD.
METHODS: This was a cross-sectional study of 7,053 adults in the general Chinese population in Southern China using a multi-stage stratified sampling method. In which associations between hyperuricemia and indicators of CKD (defined by albuminuria (urinary albumin-to -creatinine ratio ≥ 30 mg/g) or decreased modified MDRD equation estimated GFR (<60 ml/min per 1.73 m2) were tested using multivariate logistic regression.
RESULTS: After adjustment for potential confounders, hyperuricemia was associated with increased risk of reduced renal function and CKD but not albuminuria, with odds ratios (ORs) (95% CI) of 4.39 (3.38-5.70, P < 0.001), 1.54 (1.31-1.82, P <0.001) and 0.96 (0.78-1.17, P =0.671), respectively. The interaction between gender and hyperuricemia with CKD was significant (P =0.010); and stratified analysis showed a stronger association of hyperuricemia with CKD in males (OR (95% CI): 2.04 (1.56-2.67), P < 0.001) than in females (1.45 (1.17-1.80), P = 0.001).
CONCLUSIONS: We observed an independent association of hyperuricemia with CKD that was stronger in males, and this independent association in male might imply some gender specific mechanisms. These results should be confirmed in future prospective studies.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22948067     DOI: 10.1159/000341486

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  2 in total

1.  Rationale and design for Lowering-hyperUricaemia treatment on cardiovascular outcoMes In peritoNeal diAlysis patients: a prospective, multicentre, double-blind, randomised controlled trial (LUMINA).

Authors:  Wei Chen; Naya Huang; Haiping Mao; Xiao Yang; Qian Zhou; Lanping Jiang; Jun Ding; Qiong Feng; Xueqing Yu
Journal:  BMJ Open       Date:  2020-10-10       Impact factor: 2.692

2.  Hyperuricemia prevalence and its association with metabolic disorders: a multicenter retrospective real-world study in China.

Authors:  Shuguang Pang; Qiang Jiang; Pei Sun; Yi Li; Yanhua Zhu; Jin Liu; Xiaoran Ye; Ting Chen; Fei Zhao; Wenjun Yang
Journal:  Ann Transl Med       Date:  2021-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.